Pelvic Microbiomes of Benign and Malignant Ovarian Diseases (MTBOD-1)
The Role of Pelvic Microbiomes During the Malignant Transformation of Benign Ovarian Diseases
Sponsor: Academy Military Medical Science, China
A observational or N/A phase clinical study on Microbiota and Ovarian Neoplasms, this trial is ongoing. The trial is conducted by Academy Military Medical Science, China and has accumulated 13 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Feb 2021 — Dec 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Dec 2018 — Nov 2020 [monthly]
Recruiting
-
Aug 2018 — Dec 2018 [monthly]
Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Academy Military Medical Science, China
- Lei Li
For direct contact, visit the study record on ClinicalTrials.gov .